This webinar will include an overview of the collaboration between the ALS Therapy Development Institute and the Gladstone Institutes. The collaboration, announced in December 2012, couples high-content screening of compounds using Nobel Prize winning stem cell model technology at the Gladstone with the world's most rigorous preclinical drug evaluation program at TDI. Steven Finkbeiner, M.D., Ph.D. (Gladstone) and Steve Perrin, Ph.D. (TDI) will join as panelists |